ARTICLE | Clinical News
Medivir preclinical data
April 3, 2006 7:00 AM UTC
Researchers published in Antimicrobial Agents and Chemotherapy that MIV-210, a nucleoside analog prodrug of 3'-fluoro-2', 3'-dideoxyguanosine (FLG), was active against both lamivudine- and adefovir-re...